My experience with novel immunotherapies
During the European School of Haematology (ESH) 5th Translational Research E-Conference on Multiple Myeloma, the Multiple Myeloma Hub was pleased to speak to Hermann Einsele, University of Würzburg, Würzburg, DE, about novel immunotherapies.
Bispecific antibodies and chimeric antigen receptor (CAR) T cells represent a novel interesting therapeutic option for patients with multiple myeloma. In this podcast, after explaining their mechanism of action, Hermann Einsele gives an overview of the major findings from clinical trials evaluating efficacy and safety of bispecific antibodies and CAR T…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.